Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promoters

Gene Therapy
S RubinchikJ Y Dong

Abstract

Tissue-specific transgene expression is a valuable research tool and is of great importance in delivering toxic gene products with adenovirus vectors to tumors. Limiting cytotoxic gene expression to the target cells is highly desirable. While a number of successful applications of tissue- and tumor-specific gene expression using Ad vectors has been reported, cloning of some promoters into Ad vectors resulted in modulation or loss of tissue specificity. This phenomenon is likely the result of the interaction of E1A enhancer (and possibly other Ad sequences) with the promoter cloned in the E1 region. We have compared performance parameters of prostate-specific and tet-regulatable promoters in plasmids containing the terminal repeat sequences of Ad5 with or without the E1A enhancer. Subsequently, adenoviral vectors were constructed containing identical expression units either in the E1 region or near the right ITR, and tested in several cell lines. Here, we report that promoters placed near the right ITR of Ad5 retain higher selectivity and lower background expression in both plasmid and adenovirus vectors. We confirm that the E1A enhancer can interfere with the desired activity of nearby promoters, and describe an alternative tra...Continue Reading

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M Gossen, H Bujard
Mar 21, 1992·Lancet·A A GutierrezK Sikora
Feb 1, 1992·Journal of Virology·M Gräble, P Hearing
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M J ImperialeJ R Nevins
Mar 22, 1996·The Journal of Biological Chemistry·E R SchuurD R Henderson
Jun 13, 1998·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·G AcsadiG Karpati
May 27, 1999·Journal of Molecular Endocrinology·S KasperR J Matusik
Dec 3, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·A HaackR Schwaab

❮ Previous
Next ❯

Citations

Oct 29, 2003·Journal of Virology·Peter LöserMoritz Hillgenberg
Nov 19, 2010·The Journal of General Virology·Christina RauschhuberAnja Ehrhardt
Aug 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Wing-Shing ChengMagnus Essand
Nov 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·S RubinchikJ Y Dong
Aug 7, 2009·FEMS Yeast Research·Tamara WriessneggerGuenther Daum
Sep 11, 2004·Viral Immunology·Huibi CaoJim Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.